D47.02 Code facturable et spécifique Systemic mastocytosis
ICD-10-CM D47.02 identifies “Systemic mastocytosis” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapitre 2: Neoplasms
Instructions du code
Inclusion terms4
- Indolent systemic mastocytosis
- Isolated bone marrow mastocytosis
- Smoldering systemic mastocytosis
- Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD)
Code also10
- , if applicable, any associated hematological non-mast cell lineage disease, such as:
- acute myeloid leukemia (C92.6-, C92.A-)
- chronic myelomonocytic leukemia (C93.1-)
- essential thrombocytosis (D47.3)
- hypereosinophilic syndrome (D72.1)
- myelodysplastic syndrome (D46.9)
- myeloproliferative syndrome (D47.1)
- non-Hodgkin lymphoma (C82-C85)
- plasma cell myeloma (C90.0-)
- polycythemia vera (D45)
Instructions des niveaux supérieurs
Chapitres 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
D37-D48 · Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)
Excludes 11
neoplasms of unspecified behavior (D49.-)
Note1
Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.
D47.0 · Mast cell neoplasms of uncertain behavior
Références de l’index officiel
Références de l’index officiel (5)
Disease, diseased (1)
- Disease, diseased › systemic tissue mast cellIndex des maladies
Mast cell (1)
- Mast cell › disease, systemic tissueIndex des maladies
Mastocytosis (3)
- Mastocytosis › indolent systemicIndex des maladies
- Mastocytosis › isolated bone marrowIndex des maladies
- Mastocytosis › systemic(indolent) (smoldering) › with an associated hematological non-mast cell lineage disease(SM-AHNMD)Index des maladies
Historique officiel de conversion
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Attribution précédente: D47.0
Références depuis d’autres codes (4)
Excludes 1 · indolent mastocytosis (D47.02)
Excludes 1 · (indolent) systemic mastocytosis (D47.02)
Excludes 1 · systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
Excludes 1 · systemic mastocytosis (D47.02)
Historique
Historique du code
Dernière modification enregistrée · FY2019
En vigueur dès le
- Instructions héritées modifiées
Systemic mastocytosis
Code de diagnostic facturable
CDC/NCHS · FY2019Toutes les éditions (17)
| Toutes les éditions | En vigueur dès le | Historique du code |
|---|---|---|
| FY2018 | 2017-10-01 | Ajouté |
| FY2019 | 2018-10-01 | Instructions héritées modifiées |
| FY2020 | 2019-10-01 | Aucun changement tabulaire |
| FY2020 · April | 2020-04-01 | Aucun changement tabulaire |
| FY2021 | 2020-10-01 | Aucun changement tabulaire |
| FY2021 · 01-01 | 2021-01-01 | Aucun changement tabulaire |
| FY2022 | 2021-10-01 | Aucun changement tabulaire |
| FY2022 · 04-01 | 2022-04-01 | Aucun changement tabulaire |
| FY2023 | 2022-10-01 | Aucun changement tabulaire |
| FY2023 · 04-01 | 2023-04-01 | Aucun changement tabulaire |
| FY2024 | 2023-10-01 | Aucun changement tabulaire |
| FY2024 · 04-01 | 2024-04-01 | Aucun changement tabulaire |
| FY2025 | 2024-10-01 | Aucun changement tabulaire |
| FY2025 · 04-01 | 2025-04-01 | Aucun changement tabulaire |
| FY2026 | 2025-10-01 | Aucun changement tabulaire |
| FY2026 · April | 2026-04-01 | Aucun changement tabulaire |
| FY2027 | 2026-10-01 | Aucun changement tabulaire |
Correspondances ICD-9 historiques · 2018
Correspondance historique uniquement ; pas de substitution automatique.
- 238.5 · Approximative
Cette entrée est un code complet dans l’édition sélectionnée. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.